ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,492, issued on Feb. 18, was assigned to Florida A&M University (Tallahassee, Fla.).
"Pyrimidine nucleosides as anticancer agents against pancreatic cancer" was invented by Edward Agyare (Tallahassee, Fla.), Xue You Zhu (Tallahassee, Fla.), Andriana Inkoom (Tallahassee, Fla.) and Nkafu Bechem Ndemazie (Tallahassee, Fla.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Novel compounds and methods of using the compounds and compositions to treat pancreatic cancer are presented. Novel compounds N-(5-fluoro-2-oxo-1-(tetrahydrofuran-2-yl)-1,2-dihydropyrimidin-4-yl)octanamide and N-(5-fluoro-2-oxo-1-(tetrahydrofuran-2-yl)-1,2-dihydropyrimidin-4-yl)dodecanami...